FDA approves Telix brain cancer imaging drug Pixclara
Md Babul Hosen/iStock via Getty Images
The Food and Drug Administration approved Telix Pharmaceuticals’ (TLX) Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the company said Sunday.
Pixclara, also known as floretyrosine F 18, is approved for use with positron emission tomography to help
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.